Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Navika D Shukla; Ameen A Salahudeen; Gregory A Taylor; Suresh S Ramalingam; Everett E Vokes; Glenwood D Goss; Roy H Decker; Karen Kelly; Giorgio V Scagliotti; Tony S Mok; Heather A Wakelee

doi:10.1016/j.cllc.2018.03.004

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy

Clin Lung Cancer. 2018 Sep;19(5):377-386. doi: 10.1016/j.cllc.2018.03.004. Epub 2018 Mar 17.

Authors

Affiliations

¹ Stanford University School of Medicine, Li Ka Shing Center, Stanford, CA.
² Division of Hematology, Department of Medicine, Stanford University, Stanford, CA.
³ Stanford University, Stanford, CA.
⁴ Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
⁵ Department of Medicine, University of Chicago School of Medicine, Chicago, IL.
⁶ Division of Oncology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
⁷ Yale University School of Medicine, New Haven, CT.
⁸ Department of Internal Medicine, University of California-Davis Comprehensive Cancer Center, Sacramento, CA.
⁹ Medical Oncology, Department of Oncology, University of Turin, Azienda Ospedaliera Universitaria San Luigi, Orbassano, Turin, Italy.
¹⁰ Department of Clinical Oncology, Chinese Medical University of Hong Kong Shatin, New Territories, Hong Kong.
¹¹ Division of Oncology, Department of Medicine, Stanford University, Stanford, CA. Electronic address: hwakelee@stanford.edu.

PMID: 29653819
DOI: 10.1016/j.cllc.2018.03.004

Abstract

Cancer cooperative groups have historically played a critical role in the advancement of non-small-cell lung cancer therapy. Representatives from cooperative groups worldwide convene at the International Lung Cancer Congress annually. The International Lung Cancer Congress had its 17th anniversary in the summer of 2016. The present review highlights the thoracic malignancy studies discussed by presenters. The included studies are merely a sample of the trials of thoracic malignancies ongoing globally.

Keywords: Clinical trials; Mesothelioma; Non–small-cell lung cancer; Small cell lung cancer; Thymic carcinoma.

Publication types

Review

MeSH terms

Clinical Trials as Topic*
Humans
Immunotherapy*
International Cooperation*
Prognosis
Thoracic Neoplasms / immunology
Thoracic Neoplasms / therapy*

Grants and funding

U10 CA180888/CA/NCI NIH HHS/United States